ライフサイエンスコーパス: survivor

1 ncome population of breast cancer survivors (survivors).

2 viral shedding from sanctuary sites in EBOV survivors.

3 ifty-six acute respiratory distress syndrome survivors.

4 after stroke, occurring in 25%-40% of stroke survivors.

5 spepsia related quality of life in long-term survivors.

6 erate to severe NDI, affecting around 1 in 5 survivors.

7 n ARDS that differentiate survivors from non-survivors.

8 R) is a common problem experienced by cancer survivors.

9 d, adolescent, and young adult (CAYA) cancer survivors.

10 ut with frequent autoimmune complications in survivors.

11 zed care in limiting neurotoxicity in cancer survivors.

12 s are long-term progression free and 13% are survivors.

13 pain and can lead to long-term morbidity in survivors.

14 ear mortality 17% (95% CI, 6-40%) of 6-month survivors.

15 were greater among HCT versus non-HCT cancer survivors.

16 We surveyed 934 participants, 69.3% of known survivors.

17 sectional study of household contacts of the survivors.

18 entially expressed between survivors and non-survivors.

19 cardiac arrest pathogenesis and prognosis in survivors.

20 rted by caregivers of black and white stroke survivors.

21 stress to be different in survivors and non-survivors.

22 turity that often leads to sequelae in adult survivors.

23 shaped pattern among long-term breast cancer survivors.

24 ined in a pilot study of posttransplantation survivors.

25 cations associated with VA impairment in EVD survivors.

26 ant proportion of unexplained cardiac arrest survivors.

27 viral IgG in serum samples of long recovered survivors.

28 correlates of suicidal ideation among stroke survivors.

29 predictors of late mortality among hospital survivors.

30 , long-term sequelae are a major concern for survivors.

31 do not determine late mortality in hospital survivors.

32 s were enumerated and described in long-term survivors.

33 have resulted in increasing numbers of BHFS survivors.

34 challenges of this growing population of ICU survivors.

35 e autoantibodies was confirmed in human EBOV survivors.

36 was robust in analyses restricted to 6-month survivors.

37 the prevention of prolonged frailty in burn survivors.

38 reproductive counseling of female AYA cancer survivors.

39 s life-long risk-based monitoring of the BMT survivors.

40 Of 1914 eligible survivors, 1503 were assessed (mean gestational age was

41 Of 305 PD survivors, 245 (80.3%) responded, of whom 157 (64.1%) un

42 Of meningitis survivors, 32% (95% CI, 25%-38%) had NDI at 18 months of

43 ired infections occurred in 211 of the 3-day survivors (33%).

44 Of 922 consenting survivors, 386 (42%) were employed before ARDS (56% male

45 months for all patients and 79.6 months for survivors, 64 patients were enrolled and analyzed; inclu

46 Dialysis dependency was more frequent among survivors 80 years old or older (30% vs 14%; p = 0.001).

47 ncreases of >0.25 units from baseline (3/130 survivors; 9/28 who died) significantly increased the ri

48 ervention for African American breast cancer survivors (AABCS) on weight, body composition, and behav

49 sus 3), especially among head and neck tumor survivors (absolute excess risks =30 versus 11).

50 ealth status outcomes among childhood cancer survivors across 3 decades.

51 im to integrate PCPs into the care of cancer survivors across different settings.

52 use in all clinical research evaluating ARF survivors after hospital discharge.

53 ng the outcomes of acute respiratory failure survivors after hospital discharge.

54 t from treatment-associated adverse effects, survivors after initially successful therapy for cHL are

55 bile reflux are common concerns in long-term survivors after Whipple surgery.

56 Initiation in adolescent survivors (ages 13 to 17 years) was 22.0% (95% CI, 17.3%

57 irth between childhood and adolescent cancer survivors and an age-matched comparison group.

58 cumulative incidence of second cancer in HL survivors and compared the standardized incidence ratios

59 different data platforms that differentiated survivors and fatalities early after infection.

60 c critical illness is a common trajectory in survivors and is associated with poor long-term outcomes

61 ch 142 were differentially expressed between survivors and non-survivors.

62 mediated oxidative stress to be different in survivors and non-survivors.

63 rences in comorbidities or cytokines between survivors and the control group.

64 iving), were used to identify elderly stroke survivors and their caregivers.

65 s not commonly completely lesioned in stroke survivors and this heterogeneity may have prevented its

66 scribe ocular complications afflicting these survivors and to observe their occurrence and recurrence

67 was affecting 24% (95% CI, 5-63%) of 1-month survivors, and 1-year mortality 17% (95% CI, 6-40%) of 6

68 nical researchers, acute respiratory failure survivors, and caregivers that rated the importance of 1

69 ts, increased research burden among disaster survivors approached by multiple research teams, and pot

70 Purpose Cancer survivors are at high risk for human papillomavirus (HPV

71 usion HPV vaccine initiation rates in cancer survivors are low.

72 Breast cancer survivors are more likely to develop mood disorders and

73 the antigen specificity of T cells in Ebola survivors are scarce, and our understanding of EVD patho

74 One-third of all stroke survivors are unable to walk, even after intensive physi

75 t1Delta blmDelta double mutant gives rise to survivors as readily as the trt1Delta single mutant, and

76 p-defective and flightless phenotypes of the survivors, as well as abnormal sarcomere organization.

77 he provision of routine psychosocial care to survivors, as well as the challenges present in providin

78 ound to a neutralizing antibody from a human survivor at 3.2-angstrom resolution.

79 cy threshold of at least 40 progression-free survivors at 2 years among the first 52 patients in both

80 mplete tumor regression and 10/10 tumor free survivors at a single 0.5mg/kg dose.

81 utcomes of adolescent and young adult cancer survivors (AYA [diagnosed at ages 15-39 years]) with tho

82 ong-term acute respiratory distress syndrome survivors, better annual physical and quality of life st

83 s became negative after the third ICU day in survivors but remained positive in nonsurvivors.

84 odification and discussion of individualized survivor care plans even at initial cancer diagnosis.

85 Survivor characteristics associated with medication use

86 of a first child among both male and female survivors compared with controls.

87 r 12-month mortality of 1.35 for perforation survivors compared with matched nonperforation survivors

88 r 12-month mortality of 1.60 for perforation survivors compared with matched nonperforation survivors

89 with the age- and sex-adjusted controls, PD survivors demonstrated higher global QOL (78.7 vs 69.7,

90 e, multicenter cohort study of 5-year cancer survivors diagnosed before age 21 years from pediatric t

91 ty of having a first live birth among cancer survivors diagnosed during childhood or adolescence; men

92 (CCR) was used to identify female AYA cancer survivors diagnosed from January 2000 to December 2013;

93 Compared with survivors diagnosed in 1970 to 1979, those diagnosed in

94 rt failure (HF) who are long-term chronic HF survivors differ from those with more recent HF diagnose

95 d mortality risk in the Japanese atomic bomb survivors - differences in excess relative and absolute

96 rare neutralizing antibody responses in MARV survivors diminished rapidly after the outbreak.

97 rge 1521 nondemented acute coronary syndrome survivors enrolled in TRACE (Transitions, Risks and Acti

98 a prospective cohort study of breast cancer survivors established in 2006.

99 ta single mutant, and like the single mutant survivors, exhibit almost exclusively type I-like telome

100 With the number of cancer survivors expanding quickly, the time has come for cardi

101 Jobless survivors experienced a 14% (95% confidence interval, 5-

102 brain, heart, and joints of pediatric cancer survivors for chemotherapy-induced injuries in one sessi

103 , we describe our approach to monitoring BMT survivors for risk-based screening and early detection o

104 s mapped to multiple pathways distinguishing survivors from non-survivors, including several implicat

105 ological pathways in ARDS that differentiate survivors from non-survivors.

106 ABP1 may have good potential to discriminate survivors from nonsurvivors and may improve models curre

107 In unconscious survivors from out-of-hospital cardiac arrest admitted t

108 Among survivors, functional recovery in global longitudinal st

109 At 3 and 12 months, we assessed survivors' global cognitive function with the Repeatable

110 Medicaid recipients who were the oldest ICU survivors (> 82 yr), survivors of mechanical ventilation

111 By age 50 years, a survivor had experienced, on average, 17.1 (95% CI 16.2-

112 Births to AYA cancer survivors had a significantly increased prevalence of pr

113 Methods Eligible survivors had curable breast or colorectal cancer or mel

114 with B. pseudomallei Remarkably, 70% of the survivors had no culturable bacteria in their lungs, liv

115 Both HCT and non-HCT cancer survivors had significantly greater 10-year cumulative i

116 Methotrexate-treated cancer survivors had significantly lower cerebral blood flow an

117 The large number of Ebola survivors has highlighted the frequency of persistent sy

118 sis shows that about one out of eight stroke survivors has suicidal ideation.

119 rbidity and mortality among childhood cancer survivors have been described previously.

120 t white predicted lower mortality for stroke survivors (hazard ratio, 0.75 for neighborhoods in highe

121 tential adverse effects could improve cancer survivors' health and quality of life.

122 A quantitative landscape of morbidity of survivors, however, has not been described.

123 Among 142 long-term survivors, imatinib was the sole therapy administered in

124 Of 375 cardiac arrest survivors in CASPER from 2006 to 2015, 174 underwent gen

125 Rare survivors in the absence of Srs2 rely on structure-speci

126 Results Survivors in the intervention group reported greater phy

127 ed data to estimate the percentage of cancer survivors in the United States reporting current medicat

128 isease-derived peptides identified long-term survivors in two independent datasets, whereas a neoanti

129 e care resources should be mobilized for EVD survivors in West Africa because of the frequency of thi

130 protein expression in ARDS survivors vs. non-survivors, including proteins that counter oxidative str

131 e pathways distinguishing survivors from non-survivors, including several implicated in lung injury a

132 risk of cerebral infarction among CNS tumor survivors increases with attained age.

133 n self-reported cognitive function in cancer survivors, indicating that this intervention is a feasib

134 nd growing since the mid-1980s, but the term survivor is open to debate by people living with cancer

135 ncluding uveitis and optic neuropathy in EVD survivors, level of VA impairment in EVD survivors with

136 dicine report: From cancer patient to cancer survivor: lost in transition, in 2005, there has been a

137 edicine Report From Cancer Patient to Cancer Survivor: Lost in Transition.

138 Live births to AYA cancer survivors may have an increased risk of preterm birth an

139 Overall, 2598 births to AYA cancer survivors (mean [SD] maternal age, 31 [5] years) were in

140 Among survivors (median age at diagnosis, 62 years; 56% male),

141 to identify postdiagnosis live births to AYA survivors (n = 2598).

142 rvey, years 2010 to 2013, identifying cancer survivors (n = 3,184) and adults with no history of canc

143 reams in southeastern Madagascar is the last survivor of a once dominant and widespread Mesozoic grou

144 ty of $9,099 (95% CI, $7,224 to $10,973) per survivor of cancer.

145 s of $10,280 (95% CI, $7,435 to $13,125) per survivor of cancer.

146 METHOD: In a community-based cohort study of survivors of a major bushfire disaster, participants (N=

147 onged febrile seizures (14.3%, 6.3-29.4) and survivors of acute symptomatic CSE (13.3%, 3.7-37.9) tha

148 Attention to survivors of adult cancers formally began more than 30 y

149 Among the 2855 patients who were 30-day survivors of an out-of-hospital cardiac arrest during th

150 Five generations of successive survivors of B. tabaci infected by I. fumosorosea were a

151 e associated with lower risk, and most older survivors of breast cancer will ultimately die from nonb

152 blinded, noninferiority trial that involved survivors of breast cancer with insomnia who were recrui

153 d contralateral breast cancer risks in older survivors of breast cancer, and suggested approaches for

154 ing for surveillance breast imaging in older survivors of breast cancer, with consideration of the fo

155 pact of chronic conditions was similar among survivors of cancer and individuals without a history of

156 The presence of chronic conditions among survivors of cancer was associated with substantially hi

157 For certain higher risk survivors of cancer, routine surveillance with cardiac i

158 economic effect of chronic conditions among survivors of cancer.

159 f circulatory risk and improve the triage of survivors of cardiac arrest without ST-segment-elevation

160 Survivors of central nervous system (CNS) tumors (SHR=4.

161 rld is produced as a neurological sequela in survivors of cerebral malaria.

162 Purpose Survivors of childhood acute lymphoblastic leukemia (ALL

163 Among 23603 survivors of childhood cancer (mean age at diagnosis, 7.

164 Results Among 580 survivors of childhood cancer and 173 siblings, survivor

165 opardizing care or changing lifestyle) among survivors of childhood cancer and a sibling comparison g

166 Survivors of childhood cancer are at increased risk for

167 Conclusion Survivors of childhood cancer are more likely to report

168 Survivors of childhood cancer develop early and severe c

169 population-based cohort of 34 489 five-year survivors of childhood cancer diagnosed from 1940 to 200

170 INTERPRETATION: The burden of CHCs in survivors of childhood cancer is substantial and highly

171 Purpose Survivors of childhood cancer may experience financial b

172 Purpose Survivors of childhood cancer treated with cranial radia

173 vivors of childhood cancer and 173 siblings, survivors of childhood cancer were more likely to have o

174 t primary CNS tumors and replicated these in survivors of childhood cancer with and without subsequen

175 Among survivors of childhood cancer, a higher percentage of in

176 Among survivors of childhood cancer, the risk of subsequent ma

177 ischemic heart disease and stroke in 5-year survivors of childhood cancer.

178 ally assessed ageing population of long-term survivors of childhood cancer.

179 are associated with subsequent neoplasms in survivors of childhood cancer.

180 rade 1-5 CHCs at age 50 years was highest in survivors of CNS malignancies (24.2 [95% CI 20.9-27.5])

181 lidation survey (among 276 patients with and survivors of colorectal cancer between October 15, 2015,

182 omparison of somatosensory functions between survivors of critical illness 6 months after ICU dischar

183 Survivors of critical illness have an increased prevalen

184 ith simvastatin would decrease the time that survivors of critical illness spent in delirium or coma.

185 nd reduced health-related quality of life in survivors of critical illness.

186 surance coverage among older (>/= 65 yr old) survivors of critical illness.

187 Immune responses in survivors of Ebola virus (EBOV) and Sudan virus (SUDV) i

188 veitis with visual impairment in a cohort of survivors of Ebola virus disease (EVD) in Monrovia, Libe

189 ly present in the semen of a large number of survivors of Ebola virus disease (EVD) in Western Africa

190 olled a convenience sample of 220 adult male survivors of EVD in Sierra Leone, at various times after

191 e of Ebola virus RNA in semen in a cohort of survivors of EVD in Sierra Leone.

192 A total of 96 survivors of EVD were examined.

193 blast wave pressure has been reported among survivors of explosions, but with limited understanding

194 We conducted longitudinal follow-up of all survivors of extremely preterm birth who were born in Vi

195 All 18 studies followed up survivors of GBS meningitis; only 5 of these studies als

196 is; only 5 of these studies also followed up survivors of GBS sepsis and were too few to pool in a me

197 cies (24.2 [95% CI 20.9-27.5]) and lowest in survivors of germ cell tumours (14.0 [11.5-16.6]).

198 study, nested in a cohort of 2617 five-year survivors of HL diagnosed before age 51 years during 196

199 Of the 8482 survivors of hospital encounters, 4644 (54.7%) were male

200 A total of 179,810 survivors of hospitalization with AMI without HF or LVSD

201 Here we aimed to estimate NDI in survivors of infant GBS disease.

202 th treatment decision regret among long-term survivors of localized prostate cancer.

203 nfrequently reported outcome among long-term survivors of localized prostate cancer; however, our res

204 who were the oldest ICU survivors (> 82 yr), survivors of mechanical ventilation, and discharged to s

205 Thirty-eight school-age (8-12 yr) survivors of neonatal extracorporeal membrane oxygenatio

206 is associated with heart failure (HF) among survivors of non-Hodgkin lymphoma (NHL).

207 Our assessment of total cumulative burden in survivors of paediatric cancer, with detailed characteri

208 h-quality and MUC16 neoantigens in long-term survivors of pancreatic cancer, including clones with sp

209 Survivors of preterm birth often present with medical mo

210 standardized, 30-day readmission rates among survivors of sepsis and compared rates across region, ow

211 Survivors of teenage and young adult cancer are at risk

212 Among survivors only, preexisting cardiovascular factors (hype

213 e assessment of impact of therapy on HRQL in survivors only.

214 onths after primary cancer treatment (cancer survivors) or within a comparable time frame (control gr

215 alitative study of acute respiratory failure survivors' outcomes after hospital discharge, as related

216 unit discharge had 12.4% greater costs than survivors (p < 0.01; 99% CI = 9.3-15.5%) after multivari

217 f Ebola virus RNA in the semen of male Ebola survivors participating in the Postebogui study in Guine

218 These groups of survivors, particularly males, should be considered for

219 with mortality, ICU morbidity as measured by survivor Pediatric Logistic Organ Dysfunction score, and

220 n In a large, population-based cohort of NHL survivors, preexisting cardiovascular conditions were as

221 Survivors prefer to have these needs addressed by their

222 In stark contrast to SUDV survivors, rare neutralizing antibody responses in MARV

223 reasonable to propose that we are all cancer survivors rather than cancer-free individuals because of

224 Black stroke survivors received an average of approximately 11 more h

225 emic have prompted recommendations that male survivors refrain from unprotected sex unless their seme

226 Conclusion Among long-term CRC survivors, regular use of NSAIDs after CRC diagnosis was

227 ntil recently, immune responses in filovirus survivors remained poorly understood.

228 Survivors reporting a meningioma had increased risks of

229 ssociated with changes in the proportions of survivors reporting adverse health status.

230 to 1979 and 1990 to 1999, the proportions of survivors reporting adverse outcomes were higher (P < 0.

231 Expert Panel emphasized that caring for HNC survivors requires a team-based approach that includes p

232 stdisaster), and 82.1% of the 4,380 eligible survivors responded.

233 pidemiological studies of childhood leukemia survivors reveal an alarmingly high incidence of chronic

234 Gene expression in southern survivors shifted toward patterns characteristic of nort

235 In particular, clinicians who care for HCT survivors should be aware of their high rates of late re

236 ial to reduce permanent disability in stroke survivors.SIGNIFICANCE STATEMENT The brain and spinal co

237 ective effects of CO poisoning, a portion of survivors still have substantial morbidity.

238 Methods Participants in the Childhood Cancer Survivor Study (CCSS; n = 13,060) were observed through

239 The British Childhood Cancer Survivor Study is a population-based cohort of 34 489 fi

240 pmental delay as we find 20% (11/55) of BHFS survivors suffer from a serious delay of >/=6 months.

241 ong a low-income population of breast cancer survivors (survivors).

242 therapeutic clinical trials, and analyses of survivor syndrome.

243 xiety and depression and to characterize the survivors taking this type of medication.

244 health outcomes (AHOs) in testicular cancer survivors (TCSs) after four cycles of etoposide and cisp

245 Among hospital survivors, the 1-month, 3-month, 1-year, and 5-year surv

246 Among survivors, those treated with HCT had higher median Karn

247 , a longer median duration of ventilation in survivors to day 90 (16 days [IQR 13-30] in the KGF grou

248 survivors were more likely than white stroke survivors to have a caregiver (62.5% versus 49.7%; P<0.0

249 Methods Two-year HCT survivors treated at a comprehensive cancer center from

250 However, survivors treated with HCT experienced somewhat greater

251 Hodgkin lymphoma (HL) survivors treated with radiotherapy and/or chemotherapy

252 Four hundred thirty-two cardiac arrest survivors underwent targeted temperature management; of

253 sis (as applicable) to non-HCT 2-year cancer survivors, using the state cancer registry (n = 5,455) a

254 ong hematopoietic cell transplantation (HCT) survivors versus a matched population of patients with c

255 evalence of HPV vaccine initiation in cancer survivors versus the US population and examined predicto

256 ences in the BALF protein expression in ARDS survivors vs. non-survivors, including proteins that cou

257 proportion of suicidal ideation among stroke survivors was 11.8% (7.4% to 16.2%), with high heterogen

258 Materials and Methods A total of 1,206 survivors was included in the study, together with 2,412

259 s Overall, the risk of a second cancer in HL survivors was increased 2.39-fold (95% CI, 2.29 to 2.53)

260 ies promoting T-cell activation in long-term survivors, we discovered that these individuals were enr

261 erties discriminated between fatal cases and survivors, we identify a small panel of responding genes

262 Survivors were 2.5 times and 5.9 times more at risk of i

263 urveys of 1225 multinational BC patients and survivors were also conducted to obtain patients' input.

264 Rates of medication use in cancer survivors were compared with rates in the general popula

265 More than 50% of these survivors were functionally independent or required mini

266 years of age, every year, 0.4% of CNS tumor survivors were hospitalized for a cerebral infarction (v

267 age, every year, 0.2% of head and neck tumor survivors were hospitalized for a cerebral infarction (v

268 Overall, 2782 cancer survivors were hospitalized for a cerebrovascular event-

269 Out of 43 patients operated, 23 long-term survivors were included.

270 ARDS, nearly one-half of previously employed survivors were jobless.

271 Survivors were less active than control subjects, as dem

272 Black stroke survivors were more likely than white stroke survivors t

273 ith adults with no history of cancer, cancer survivors were significantly more likely to report takin

274 icating that an estimated 2.5 million cancer survivors were taking medication for anxiety or depressi

275 ir 1-year survival rate was 42%; most of the survivors were transplanted either directly or after swi

276 lity, predominantly down-classifying risk in survivors when added to clinical scores; levels <133.3 p

277 istry) is a large registry of cardiac arrest survivors where initial assessment reveals normal corona

278 for cardiac evaluation should be low in any survivor who has received potentially cardiotoxic therap

279 ry care providers (PCPs) as receiving cancer survivors who are transferred after successful treatment

280 from April to July 2016, 10 pediatric cancer survivors who completed chemotherapy underwent imaging o

281 suicidal ideation was less likely in stroke survivors who were married (OR=0.63; p<0.001), employed

282 For breast cancer survivors who wish to conceive, the risk of death is low

283 ll second cancers was 1.3-fold higher for HL survivors with a first-degree relative with cancer ( P <

284 ocardiographic follow-up was available in 10 survivors with and 16 without preeclampsia.

285 st, colorectal, and all second cancers in HL survivors with and without a site-specific family histor

286 Many stroke survivors with aphasia in the acute period experience sp

287 Survivors with cardiovascular risk factors had an increa

288 Childhood cancer survivors with hypertension after anthracycline exposure

289 veillance mammography in older breast cancer survivors with limited life expectancy are not known, an

290 METHODS AND The CASPER (Cardiac Arrest Survivors with Preserved Ejection Fraction Registry) is

291 0.88-3.33) for nonmelanoma skin cancers for survivors with reference characteristics (no chemotherap

292 ons in late mortality and the proportions of survivors with severe, disabling, or life-threatening ch

293 EVD survivors, level of VA impairment in EVD survivors with uveitis, and structural complications ass

294 LV ejection fraction recovered in 80% of survivors with versus 25% without preeclampsia (P=0.014)

295 e coordinated, comprehensive care for cancer survivors, with an emphasis on the role of primary care.

296 rvivors compared with matched nonperforation survivors without a CP (P<0.0001).

297 rvivors compared with matched nonperforation survivors without a CP (P<0.0001).

298 Survivors without neurological abnormalities before CSE

299 tely 11 more hours of care than white stroke survivors without substantial differences in unmet need.

300 the exceptional outcome of the few long-term survivors, yet the relevant antigens remain unknown.